1,783
Views
4
CrossRef citations to date
0
Altmetric
Review

The development of China’s vaccine industry in the past decade: the perspective from drug regulatory science

ORCID Icon & ORCID Icon
Pages 5666-5672 | Received 14 Sep 2021, Accepted 02 Nov 2021, Published online: 02 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hai Fang, Chen Chen, Yu Fang, Xiaoning He, Zhiyuan Hou, Minghuan Jiang, Yawen Jiang, Shunping Li, Yang Liu, Binyan Sui, Qiang Sun, Jing Wu, Tingting Xu, Juan Yang, Zundong Yin, Xiaohua Ying, Beibei Yuan, Hui Zheng & Yaming Zheng. (2022) A guideline for economic evaluations of vaccines and immunization programs in China. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (3)

Herschel Nachlis & Kyle Thomson. (2024) Emergency Regulatory Procedures, Pharmaceutical Regulatory Politics, and the Political Economy of Vaccine Regulation in the COVID-19 Pandemic. Journal of Health Politics, Policy and Law 49:1, pages 73-98.
Crossref
Xiangchuan He, Tianxiang Zhang, Shitong Huan & Yue Yang. (2023) Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses. Vaccines 11:10, pages 1573.
Crossref
Yun Lyu, Xiaozhen Lai, Yidi Ma & Hai Fang. (2023) Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China. Infectious Diseases of Poverty 12:1.
Crossref